Luis Lopez takes over as president of Fero Industries
This article was originally published in Scrip
Fero Industries has appointed Luis Lopez president, replacing Kyle Schlosser who had served the company as president and CEO since 2007. Mr Lopez was previously chief operating officer at Fero, and managing director of Pharmaroth Latin America (Fero's 98%-owned Mexican subsidiary). He has been on the company's board since September 2010.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.